Clinical Trial: A Phase I Study of HW071021 Monotherapy in Patients with Advanced Solid Tumors

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06882135) titled 'A Phase I Study of HW071021 Monotherapy in Patients with Advanced Solid Tumors' on March 07.

Brief Summary: This is a Phase I open-label study that will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of HW071021 monotherapy in patients with advanced solid tumors.

Study Start Date: March 19

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: HW071021 Tablets

Administered orally at pre-specified doses

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company

Disclaimer: Curated by HT Syndication....